RECURRENT GASTROINTESTINAL STROMAL TUMOR

Clinical trials for RECURRENT GASTROINTESTINAL STROMAL TUMOR explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GASTROINTESTINAL STROMAL TUMOR trials appear

Sign up with your email to follow new studies for RECURRENT GASTROINTESTINAL STROMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Supercharging the Body's own defenses to fight Hard-to-Treat GIST

Disease control Not yet recruiting

This trial tests whether a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), can be grown in a lab and then given back to fight advanced gastrointestinal stromal tumors (GIST). The study includes people whose GIST has spread, come back, or cannot be remove…

Matched conditions: RECURRENT GASTROINTESTINAL STROMAL TUMOR

Phase: PHASE2 • Sponsor: Joal Beane • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

RECURRENT GASTROINTESTINAL STROMAL TUMOR

Get alerted when new RECURRENT GASTROINTESTINAL STROMAL TUMOR trials appear

Supercharging the Body's own defenses to fight Hard-to-Treat GIST